Treatment of Malignant Pleural Effusion: A Cost-Effectiveness Analysis

Using decision analysis, TPC is the preferred treatment for patients with malignant pleural effusion and limited survival; BP is the most cost-effective treatment for patients with more prolonged expected survival.